|
GOLGA5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.9370999510856E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.53970003413662E-09 |
| Normal-vs-Stage2 |
1.024650E-01 |
| Normal-vs-Stage3 |
2.256900E-03 |
| Normal-vs-Stage4 |
6.821200E-03 |
| Stage1-vs-Stage2 |
6.459900E-02 |
| Stage1-vs-Stage3 |
3.693200E-01 |
| Stage1-vs-Stage4 |
2.555600E-01 |
| Stage2-vs-Stage3 |
3.514400E-01 |
| Stage2-vs-Stage4 |
4.738600E-01 |
| Stage3-vs-Stage4 |
8.492000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.10469996986262E-09 |
| Normal-vs-AfricanAmerican |
1.617840E-01 |
| Normal-vs-Asian |
3.001200E-01 |
| Caucasian-vs-AfricanAmerican |
8.887600E-02 |
| Caucasian-vs-Asian |
7.174600E-01 |
| AfricanAmerican-vs-Asian |
7.241800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.75770000016607E-07 |
| Normal-vs-Female |
2.79809999947922E-07 |
| Male-vs-Female |
3.499600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.341780E-01 |
| Normal-vs-Age(41-60Yrs) |
9.48010000501043E-08 |
| Normal-vs-Age(61-80Yrs) |
1.90209999999524E-05 |
| Normal-vs-Age(81-100Yrs) |
7.132000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.162800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.492200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.246400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.700800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.647200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.691600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.625000E-03 |
| Normal-vs-Grade 2 |
9.52499967787901E-10 |
| Normal-vs-Grade 3 |
1.214890E-04 |
| Normal-vs-Grade 4 |
3.123600E-01 |
| Grade 1-vs-Grade 2 |
3.045000E-01 |
| Grade 1-vs-Grade 3 |
6.985700E-02 |
| Grade 1-vs-Grade 4 |
9.462700E-03 |
| Grade 2-vs-Grade 3 |
4.368200E-02 |
| Grade 2-vs-Grade 4 |
2.639500E-03 |
| Grade 3-vs-Grade 4 |
1.061590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62825308791525E-12 |
| Normal-vs-ccB subtype |
4.554400E-02 |
| ccA subtype-vs-ccB subtype |
1.76959999986792E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.99590000035965E-07 |
| Normal-vs-N1 |
1.410020E-01 |
| N0-vs-N1 |
3.400300E-04 |
|
|
